Callan Family Office’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$914K Sell
18,077
-620
-3% -$38K 0.02% 619
2026
Q1
$1.22M Buy
18,697
+7,576
+68% +$554K 0.03% 503
2025
Q4
$895K Buy
11,121
+1,421
+15% +$114K 0.02% 581
2025
Q3
$796K Sell
9,700
-252
-3% -$21.8K 0.03% 420
2025
Q2
$908K Buy
9,952
+6,081
+157% +$544K 0.03% 427
2025
Q1
$354K Buy
3,871
+1,125
+41% +$98.2K 0.03% 392
2024
Q4
$234K Buy
+2,746
New +$241K 0.01% 564

Other funds holding DOX

Callan Family Office's DOX Position: Q2 2026 in Review

Callan Family Office reduced its Amdocs (DOX) stake by 3.3% in Q2 2026, selling an estimated $38K and leaving 18,077 shares worth $914K. The position accounts for 0.02% of the portfolio, ranked #619.

Callan Family Office first reported a position in DOX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.22M in Q1 2026. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Callan Family Office held 18,077 shares of Amdocs worth $914K as of Q2 2026.
  • Callan Family Office sold 620 Amdocs shares in Q2 2026, an estimated $38K.
  • Amdocs made up 0.02% of Callan Family Office's portfolio in Q2 2026, its #619 holding.
  • Callan Family Office first reported a position in Amdocs in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Amdocs position peaked at $1.22M in Q1 2026.
  • 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.